Retractable Technologies, Inc. (NYSE:RVP) CEO Buys $10,080.45 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 12,445 shares of the business’s stock in a transaction dated Monday, January 27th. The shares were purchased at an average cost of $0.81 per share, with a total value of $10,080.45. Following the acquisition, the chief executive officer now owns 15,019,308 shares in the company, valued at $12,165,639.48. This trade represents a 0.08 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link.

Retractable Technologies Stock Performance

Shares of RVP opened at $0.84 on Friday. The business has a 50-day simple moving average of $0.69 and a two-hundred day simple moving average of $0.81. Retractable Technologies, Inc. has a 12-month low of $0.56 and a 12-month high of $1.34. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 7.58% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on shares of Retractable Technologies in a report on Thursday. They set a “hold” rating on the stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.